MRVI - CIK 0001823239
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) reported revenue of $185.74M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $185.74M | -28.3% |
| FY 2024 | $259.19M | -10.3% |
| FY 2023 | $288.94M | -67.3% |
| FY 2022 | $883.00M | +10.5% |
| FY 2021 | $799.24M | +181.3% |
| FY 2020 | $284.10M | +98.5% |
| FY 2019 | $143.14M | - |
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) reported revenue of $185.74M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, MARAVAI LIFESCIENCES HOLDINGS, INC.'s revenue grew from $143.14M to $185.74M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.